These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22253144)

  • 1. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Ramus SJ; Antoniou AC; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; McGuffog L; Sinilnikova OM; Healey S; Barrowdale D; Lee A; Thomassen M; Gerdes AM; Kruse TA; Jensen UB; Skytte AB; Caligo MA; Liljegren A; Lindblom A; Olsson H; Kristoffersson U; Stenmark-Askmalm M; Melin B; ; Domchek SM; Nathanson KL; Rebbeck TR; Jakubowska A; Lubinski J; Jaworska K; Durda K; Złowocka E; Gronwald J; Huzarski T; Byrski T; Cybulski C; Toloczko-Grabarek A; Osorio A; Benitez J; Duran M; Tejada MI; Hamann U; Rookus M; van Leeuwen FE; Aalfs CM; Meijers-Heijboer HE; van Asperen CJ; van Roozendaal KE; Hoogerbrugge N; Collée JM; Kriege M; van der Luijt RB; ; ; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Lalloo F; Jacobs C; Eeles R; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Paterson J; Douglas F; Brewer C; Hodgson S; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Pathak H; Godwin AK; Stoppa-Lyonnet D; Caux-Moncoutier V; de Pauw A; Gauthier-Villars M; Mazoyer S; Léoné M; Calender A; Lasset C; Bonadona V; Hardouin A; Berthet P; Bignon YJ; Uhrhammer N; Faivre L; Loustalot C; ; Buys S; Daly M; Miron A; Terry MB; Chung WK; John EM; Southey M; Goldgar D; Singer CF; Tea MK; Pfeiler G; Fink-Retter A; Hansen Tv; Ejlertsen B; Johannsson OT; Offit K; Kirchhoff T; Gaudet MM; Vijai J; Robson M; Piedmonte M; Phillips KA; Van Le L; Hoffman JS; Ewart Toland A; Montagna M; Tognazzo S; Imyanitov E; Issacs C; Janavicius R; Lazaro C; Blanco I; Tornero E; Navarro M; Moysich KB; Karlan BY; Gross J; Olah E; Vaszko T; Teo SH; Ganz PA; Beattie MS; Dorfling CM; van Rensburg EJ; Diez O; Kwong A; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Heidemann S; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Fiebig B; Schäfer D; Caldes T; de la Hoya M; Nevanlinna H; Aittomäki K; Plante M; Spurdle AB; ; Neuhausen SL; Ding YC; Wang X; Lindor N; Fredericksen Z; Pankratz VS; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Bonanni B; Bernard L; Dolcetti R; Papi L; Ottini L; Radice P; Greene MH; Mai PL; Andrulis IL; Glendon G; Ozcelik H; ; Pharoah PD; Gayther SA; Simard J; Easton DF; Couch FJ; Chenevix-Trench G;
    Hum Mutat; 2012 Apr; 33(4):690-702. PubMed ID: 22253144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.
    Antoniou AC; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; McGuffog L; Lee A; Barrowdale D; Healey S; Sinilnikova OM; Caligo MA; Loman N; Harbst K; Lindblom A; Arver B; Rosenquist R; Karlsson P; Nathanson K; Domchek S; Rebbeck T; Jakubowska A; Lubinski J; Jaworska K; Durda K; Złowowcka-Perłowska E; Osorio A; Durán M; Andrés R; Benítez J; Hamann U; Hogervorst FB; van Os TA; Verhoef S; Meijers-Heijboer HE; Wijnen J; Gómez Garcia EB; Ligtenberg MJ; Kriege M; Collée JM; Ausems MG; Oosterwijk JC; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Lalloo F; Jacobs C; Eeles R; Adlard J; Davidson R; Cole T; Cook J; Paterson J; Douglas F; Brewer C; Hodgson S; Morrison PJ; Walker L; Rogers MT; Donaldson A; Dorkins H; Godwin AK; Bove B; Stoppa-Lyonnet D; Houdayer C; Buecher B; de Pauw A; Mazoyer S; Calender A; Léoné M; Bressac-de Paillerets B; Caron O; Sobol H; Frenay M; Prieur F; Ferrer SU; Mortemousque I; Buys S; Daly M; Miron A; Terry MU; Hopper JL; John EM; Southey M; Goldgar D; Singer CF; Fink-Retter A; Tea MK; Kaulich DU; Hansen TV; Nielsen FC; Barkardottir RB; Gaudet M; Kirchhoff T; Joseph V; Dutra-Clarke A; Offit K; Piedmonte M; Kirk J; Cohn D; Hurteau J; Byron J; Fiorica J; Toland AE; Montagna M; Oliani C; Imyanitov E; Isaacs C; Tihomirova L; Blanco I; Lazaro C; Teulé A; Valle JD; Gayther SA; Odunsi K; Gross J; Karlan BY; Olah E; Teo SH; Ganz PA; Beattie MS; Dorfling CM; van Rensburg EU; Diez O; Kwong A; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Heidemann S; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Fiebig B; Schäfer D; Caldes T; de la Hoya M; Nevanlinna H; Muranen TA; Lespérance B; Spurdle AB; Neuhausen SL; Ding YC; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Bonanni B; Bernard L; Dolcetti R; Papi L; Ottini L; Radice P; Greene MH; Loud JT; Andrulis IL; Ozcelik H; Mulligan AU; Glendon G; Thomassen M; Gerdes AM; Jensen UB; Skytte AB; Kruse TA; Chenevix-Trench G; Couch FJ; Simard J; Easton DF; ; ; ; ;
    Breast Cancer Res; 2012 Feb; 14(1):R33. PubMed ID: 22348646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
    Antoniou AC; Sinilnikova OM; McGuffog L; Healey S; Nevanlinna H; Heikkinen T; Simard J; Spurdle AB; Beesley J; Chen X; ; Neuhausen SL; Ding YC; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Peissel B; Bonanni B; Viel A; Bernard L; Radice P; Szabo CI; Foretova L; Zikan M; Claes K; Greene MH; Mai PL; Rennert G; Lejbkowicz F; Andrulis IL; Ozcelik H; Glendon G; ; Gerdes AM; Thomassen M; Sunde L; Caligo MA; Laitman Y; Kontorovich T; Cohen S; Kaufman B; Dagan E; Baruch RG; Friedman E; Harbst K; Barbany-Bustinza G; Rantala J; Ehrencrona H; Karlsson P; Domchek SM; Nathanson KL; Osorio A; Blanco I; Lasa A; Benítez J; Hamann U; Hogervorst FB; Rookus MA; Collee JM; Devilee P; Ligtenberg MJ; van der Luijt RB; Aalfs CM; Waisfisz Q; Wijnen J; van Roozendaal CE; ; Peock S; Cook M; Frost D; Oliver C; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Cole T; Hodgson S; ; Godwin AK; Stoppa-Lyonnet D; Buecher B; Léoné M; Bressac-de Paillerets B; Remenieras A; Caron O; Lenoir GM; Sevenet N; Longy M; Ferrer SF; Prieur F; ; Goldgar D; Miron A; John EM; Buys SS; Daly MB; Hopper JL; Terry MB; Yassin Y; ; Singer C; Gschwantler-Kaulich D; Staudigl C; Hansen Tv; Barkardottir RB; Kirchhoff T; Pal P; Kosarin K; Offit K; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov EN; Allavena A; Schmutzler RK; Versmold B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Deissler H; Fiebig B; Suttner C; Schönbuchner I; Gadzicki D; Caldes T; de la Hoya M; Pooley KA; Easton DF; Chenevix-Trench G;
    Hum Mol Genet; 2009 Nov; 18(22):4442-56. PubMed ID: 19656774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
    Antoniou AC; Kartsonaki C; Sinilnikova OM; Soucy P; McGuffog L; Healey S; Lee A; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Cattaneo E; Barile M; Pensotti V; Pasini B; Dolcetti R; Giannini G; Putignano AL; Varesco L; Radice P; Mai PL; Greene MH; Andrulis IL; Glendon G; Ozcelik H; Thomassen M; Gerdes AM; Kruse TA; Birk Jensen U; Crüger DG; Caligo MA; Laitman Y; Milgrom R; Kaufman B; Paluch-Shimon S; Friedman E; Loman N; Harbst K; Lindblom A; Arver B; Ehrencrona H; Melin B; ; Nathanson KL; Domchek SM; Rebbeck T; Jakubowska A; Lubinski J; Gronwald J; Huzarski T; Byrski T; Cybulski C; Gorski B; Osorio A; Ramón y Cajal T; Fostira F; Andrés R; Benitez J; Hamann U; Hogervorst FB; Rookus MA; Hooning MJ; Nelen MR; van der Luijt RB; van Os TA; van Asperen CJ; Devilee P; Meijers-Heijboer HE; Gómez Garcia EB; ; Peock S; Cook M; Frost D; Platte R; Leyland J; Evans DG; Lalloo F; Eeles R; Izatt L; Adlard J; Davidson R; Eccles D; Ong KR; Cook J; Douglas F; Paterson J; Kennedy MJ; Miedzybrodzka Z; ; Godwin A; Stoppa-Lyonnet D; Buecher B; Belotti M; Tirapo C; Mazoyer S; Barjhoux L; Lasset C; Leroux D; Faivre L; Bronner M; Prieur F; Nogues C; Rouleau E; Pujol P; Coupier I; Frénay M; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Tea MK; Pfeiler G; Dressler AC; Hansen Tv; Jønson L; Ejlertsen B; Barkardottir RB; Kirchhoff T; Offit K; Piedmonte M; Rodriguez G; Small L; Boggess J; Blank S; Basil J; Azodi M; Toland AE; Montagna M; Tognazzo S; Agata S; Imyanitov E; Janavicius R; Lazaro C; Blanco I; Pharoah PD; Sucheston L; Karlan BY; Walsh CS; Olah E; Bozsik A; Teo SH; Seldon JL; Beattie MS; van Rensburg EJ; Sluiter MD; Diez O; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ruehl I; Varon-Mateeva R; Kast K; Deissler H; Niederacher D; Arnold N; Gadzicki D; Schönbuchner I; Caldes T; de la Hoya M; Nevanlinna H; Aittomäki K; Dumont M; Chiquette J; Tischkowitz M; Chen X; Beesley J; Spurdle AB; ; Neuhausen SL; Chun Ding Y; Fredericksen Z; Wang X; Pankratz VS; Couch F; Simard J; Easton DF; Chenevix-Trench G;
    Hum Mol Genet; 2011 Aug; 20(16):3304-21. PubMed ID: 21593217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
    Mavaddat N; Peock S; Frost D; Ellis S; Platte R; Fineberg E; Evans DG; Izatt L; Eeles RA; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Brewer C; Tischkowitz M; Douglas F; Hodgson S; Walker L; Porteous ME; Morrison PJ; Side LE; Kennedy MJ; Houghton C; Donaldson A; Rogers MT; Dorkins H; Miedzybrodzka Z; Gregory H; Eason J; Barwell J; McCann E; Murray A; Antoniou AC; Easton DF;
    J Natl Cancer Inst; 2013 Jun; 105(11):812-22. PubMed ID: 23628597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
    Couch FJ; Gaudet MM; Antoniou AC; Ramus SJ; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; Wang X; Kirchhoff T; McGuffog L; Barrowdale D; Lee A; Healey S; Sinilnikova OM; Andrulis IL; ; Ozcelik H; Mulligan AM; Thomassen M; Gerdes AM; Jensen UB; Skytte AB; Kruse TA; Caligo MA; von Wachenfeldt A; Barbany-Bustinza G; Loman N; Soller M; Ehrencrona H; Karlsson P; ; Nathanson KL; Rebbeck TR; Domchek SM; Jakubowska A; Lubinski J; Jaworska K; Durda K; Zlowocka E; Huzarski T; Byrski T; Gronwald J; Cybulski C; Górski B; Osorio A; Durán M; Tejada MI; Benitez J; Hamann U; Hogervorst FB; ; van Os TA; van Leeuwen FE; Meijers-Heijboer HE; Wijnen J; Blok MJ; Kets M; Hooning MJ; Oldenburg RA; Ausems MG; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Jacobs C; Eeles RA; Adlard J; Davidson R; Eccles DM; Cole T; Cook J; Paterson J; Brewer C; Douglas F; Hodgson SV; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Side LE; ; Bove B; Godwin AK; Stoppa-Lyonnet D; ; Fassy-Colcombet M; Castera L; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Bressac-de Paillerets B; Caron O; Pujol P; Coupier I; Delnatte C; Akloul L; Lynch HT; Snyder CL; Buys SS; Daly MB; Terry M; Chung WK; John EM; Miron A; Southey MC; Hopper JL; Goldgar DE; Singer CF; Rappaport C; Tea MK; Fink-Retter A; Hansen TV; Nielsen FC; Arason A; Vijai J; Shah S; Sarrel K; Robson ME; Piedmonte M; Phillips K; Basil J; Rubinstein WS; Boggess J; Wakeley K; Ewart-Toland A; Montagna M; Agata S; Imyanitov EN; Isaacs C; Janavicius R; Lazaro C; Blanco I; Feliubadalo L; Brunet J; Gayther SA; Pharoah PP; Odunsi KO; Karlan BY; Walsh CS; Olah E; Teo SH; Ganz PA; Beattie MS; van Rensburg EJ; Dorfling CM; Diez O; Kwong A; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Heidemann S; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Fiebig B; Heinritz W; Caldes T; de la Hoya M; Muranen TA; Nevanlinna H; Tischkowitz MD; Spurdle AB; Neuhausen SL; Ding YC; Lindor NM; Fredericksen Z; Pankratz VS; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Bernard L; Viel A; Giannini G; Varesco L; Radice P; Greene MH; Mai PL; Easton DF; Chenevix-Trench G; ; Offit K; Simard J;
    Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):645-57. PubMed ID: 22351618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
    Couch FJ; Wang X; McGuffog L; Lee A; Olswold C; Kuchenbaecker KB; Soucy P; Fredericksen Z; Barrowdale D; Dennis J; Gaudet MM; Dicks E; Kosel M; Healey S; Sinilnikova OM; Lee A; Bacot F; Vincent D; Hogervorst FB; Peock S; Stoppa-Lyonnet D; Jakubowska A; ; Radice P; Schmutzler RK; ; Domchek SM; Piedmonte M; Singer CF; Friedman E; Thomassen M; ; Hansen TV; Neuhausen SL; Szabo CI; Blanco I; Greene MH; Karlan BY; Garber J; Phelan CM; Weitzel JN; Montagna M; Olah E; Andrulis IL; Godwin AK; Yannoukakos D; Goldgar DE; Caldes T; Nevanlinna H; Osorio A; Terry MB; Daly MB; van Rensburg EJ; Hamann U; Ramus SJ; Toland AE; Caligo MA; Olopade OI; Tung N; Claes K; Beattie MS; Southey MC; Imyanitov EN; Tischkowitz M; Janavicius R; John EM; Kwong A; Diez O; Balmaña J; Barkardottir RB; Arun BK; Rennert G; Teo SH; Ganz PA; Campbell I; van der Hout AH; van Deurzen CH; Seynaeve C; Gómez Garcia EB; van Leeuwen FE; Meijers-Heijboer HE; Gille JJ; Ausems MG; Blok MJ; Ligtenberg MJ; Rookus MA; Devilee P; Verhoef S; van Os TA; Wijnen JT; ; ; Frost D; Ellis S; Fineberg E; Platte R; Evans DG; Izatt L; Eeles RA; Adlard J; Eccles DM; Cook J; Brewer C; Douglas F; Hodgson S; Morrison PJ; Side LE; Donaldson A; Houghton C; Rogers MT; Dorkins H; Eason J; Gregory H; McCann E; Murray A; Calender A; Hardouin A; Berthet P; Delnatte C; Nogues C; Lasset C; Houdayer C; Leroux D; Rouleau E; Prieur F; Damiola F; Sobol H; Coupier I; Venat-Bouvet L; Castera L; Gauthier-Villars M; Léoné M; Pujol P; Mazoyer S; Bignon YJ; ; Złowocka-Perłowska E; Gronwald J; Lubinski J; Durda K; Jaworska K; Huzarski T; Spurdle AB; Viel A; Peissel B; Bonanni B; Melloni G; Ottini L; Papi L; Varesco L; Tibiletti MG; Peterlongo P; Volorio S; Manoukian S; Pensotti V; Arnold N; Engel C; Deissler H; Gadzicki D; Gehrig A; Kast K; Rhiem K; Meindl A; Niederacher D; Ditsch N; Plendl H; Preisler-Adams S; Engert S; Sutter C; Varon-Mateeva R; Wappenschmidt B; Weber BH; Arver B; Stenmark-Askmalm M; Loman N; Rosenquist R; Einbeigi Z; Nathanson KL; Rebbeck TR; Blank SV; Cohn DE; Rodriguez GC; Small L; Friedlander M; Bae-Jump VL; Fink-Retter A; Rappaport C; Gschwantler-Kaulich D; Pfeiler G; Tea MK; Lindor NM; Kaufman B; Shimon Paluch S; Laitman Y; Skytte AB; Gerdes AM; Pedersen IS; Moeller ST; Kruse TA; Jensen UB; Vijai J; Sarrel K; Robson M; Kauff N; Mulligan AM; Glendon G; Ozcelik H; Ejlertsen B; Nielsen FC; Jønson L; Andersen MK; Ding YC; Steele L; Foretova L; Teulé A; Lazaro C; Brunet J; Pujana MA; Mai PL; Loud JT; Walsh C; Lester J; Orsulic S; Narod SA; Herzog J; Sand SR; Tognazzo S; Agata S; Vaszko T; Weaver J; Stavropoulou AV; Buys SS; Romero A; de la Hoya M; Aittomäki K; Muranen TA; Duran M; Chung WK; Lasa A; Dorfling CM; Miron A; ; Benitez J; Senter L; Huo D; Chan SB; Sokolenko AP; Chiquette J; Tihomirova L; Friebel TM; Agnarsson BA; Lu KH; Lejbkowicz F; James PA; Hall P; Dunning AM; Tessier D; Cunningham J; Slager SL; Wang C; Hart S; Stevens K; Simard J; Pastinen T; Pankratz VS; Offit K; Easton DF; Chenevix-Trench G; Antoniou AC;
    PLoS Genet; 2013; 9(3):e1003212. PubMed ID: 23544013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers.
    Laitman Y; Kuchenbaecker KB; Rantala J; Hogervorst F; Peock S; Godwin AK; Arason A; Kirchhoff T; Offit K; Isaacs C; Schmutzler RK; Wappenschmidt B; Nevanlinna H; Chen X; Chenevix-Trench G; Healey S; Couch F; Peterlongo P; Radice P; Nathanson KL; Caligo MA; Neuhausen SL; Ganz P; Sinilnikova OM; McGuffog L; Easton DF; Antoniou AC; Wolf I; Friedman E
    Breast Cancer Res Treat; 2012 Apr; 132(3):1119-26. PubMed ID: 22212556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
    Ramus SJ; Kartsonaki C; Gayther SA; Pharoah PD; Sinilnikova OM; Beesley J; Chen X; McGuffog L; Healey S; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Allavena A; Ottini L; Papi L; Gismondi V; Capra F; Radice P; Greene MH; Mai PL; Andrulis IL; Glendon G; Ozcelik H; ; Thomassen M; Gerdes AM; Kruse TA; Cruger D; Jensen UB; Caligo MA; Olsson H; Kristoffersson U; Lindblom A; Arver B; Karlsson P; Stenmark Askmalm M; Borg A; Neuhausen SL; Ding YC; Nathanson KL; Domchek SM; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Gronwald J; Górski B; Cybulski C; Dębniak T; Osorio A; Durán M; Tejada MI; Benítez J; Hamann U; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Bodmer D; Ausems MG; van Os TA; Asperen CJ; Blok MJ; Meijers-Heijboer HE; ; ; Peock S; Cook M; Oliver C; Frost D; Dunning AM; Evans DG; Eeles R; Pichert G; Cole T; Hodgson S; Brewer C; Morrison PJ; Porteous M; Kennedy MJ; Rogers MT; Side LE; Donaldson A; Gregory H; Godwin A; Stoppa-Lyonnet D; Moncoutier V; Castera L; Mazoyer S; Barjhoux L; Bonadona V; Leroux D; Faivre L; Lidereau R; Nogues C; Bignon YJ; Prieur F; Collonge-Rame MA; Venat-Bouvet L; Fert-Ferrer S; ; Miron A; Buys SS; Hopper JL; Daly MB; John EM; Terry MB; Goldgar D; ; Hansen Tv; Jønson L; Ejlertsen B; Agnarsson BA; Offit K; Kirchhoff T; Vijai J; Dutra-Clarke AV; Przybylo JA; Montagna M; Casella C; Imyanitov EN; Janavicius R; Blanco I; Lázaro C; Moysich KB; Karlan BY; Gross J; Beattie MS; Schmutzler R; Wappenschmidt B; Meindl A; Ruehl I; Fiebig B; Sutter C; Arnold N; Deissler H; Varon-Mateeva R; Kast K; Niederacher D; Gadzicki D; Caldes T; de la Hoya M; Nevanlinna H; Aittomäki K; Simard J; Soucy P; ; Spurdle AB; Holland H; Chenevix-Trench G; Easton DF; Antoniou AC;
    J Natl Cancer Inst; 2011 Jan; 103(2):105-16. PubMed ID: 21169536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
    Gaudet MM; Kuchenbaecker KB; Vijai J; Klein RJ; Kirchhoff T; McGuffog L; Barrowdale D; Dunning AM; Lee A; Dennis J; Healey S; Dicks E; Soucy P; Sinilnikova OM; Pankratz VS; Wang X; Eldridge RC; Tessier DC; Vincent D; Bacot F; Hogervorst FB; Peock S; Stoppa-Lyonnet D; ; Peterlongo P; Schmutzler RK; Nathanson KL; Piedmonte M; Singer CF; Thomassen M; ; Hansen Tv; Neuhausen SL; Blanco I; Greene MH; Garber J; Weitzel JN; Andrulis IL; Goldgar DE; D'Andrea E; Caldes T; Nevanlinna H; Osorio A; van Rensburg EJ; Arason A; Rennert G; van den Ouweland AM; van der Hout AH; Kets CM; Aalfs CM; Wijnen JT; Ausems MG; ; ; Frost D; Ellis S; Fineberg E; Platte R; Evans DG; Jacobs C; Adlard J; Tischkowitz M; Porteous ME; Damiola F; ; Golmard L; Barjhoux L; Longy M; Belotti M; Ferrer SF; Mazoyer S; Spurdle AB; Manoukian S; Barile M; Genuardi M; Arnold N; Meindl A; Sutter C; Wappenschmidt B; Domchek SM; Pfeiler G; Friedman E; Jensen UB; Robson M; Shah S; Lazaro C; Mai PL; Benitez J; Southey MC; Schmidt MK; Fasching PA; Peto J; Humphreys MK; Wang Q; Michailidou K; Sawyer EJ; Burwinkel B; Guénel P; Bojesen SE; Milne RL; Brenner H; Lochmann M; ; Aittomäki K; Dörk T; Margolin S; Mannermaa A; Lambrechts D; Chang-Claude J; Radice P; Giles GG; Haiman CA; Winqvist R; Devillee P; García-Closas M; Schoof N; Hooning MJ; Cox A; Pharoah PD; Jakubowska A; Orr N; González-Neira A; Pita G; Alonso MR; Hall P; Couch FJ; Simard J; Altshuler D; Easton DF; Chenevix-Trench G; Antoniou AC; Offit K
    PLoS Genet; 2013; 9(3):e1003173. PubMed ID: 23544012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Wang X; Pankratz VS; Fredericksen Z; Tarrell R; Karaus M; McGuffog L; Pharaoh PD; Ponder BA; Dunning AM; Peock S; Cook M; Oliver C; Frost D; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Houdayer C; ; Hogervorst FB; Hooning MJ; Ligtenberg MJ; ; Spurdle A; Chenevix-Trench G; ; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Domchek SM; Nathanson KL; Rebbeck TR; Singer CF; Gschwantler-Kaulich D; Dressler C; Fink A; Szabo CI; Zikan M; Foretova L; Claes K; Thomas G; Hoover RN; Hunter DJ; Chanock SJ; Easton DF; Antoniou AC; Couch FJ
    Hum Mol Genet; 2010 Jul; 19(14):2886-97. PubMed ID: 20418484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers.
    Stevens KN; Wang X; Fredericksen Z; Pankratz VS; Greene MH; Andrulis IL; Thomassen M; Caligo M; ; Nathanson KL; Jakubowska A; Osorio A; Hamann U; Godwin AK; Stoppa-Lyonnet D; Southey M; Buys SS; Singer CF; Hansen TV; Arason A; Offit K; Piedmonte M; Montagna M; Imyanitov E; Tihomirova L; Sucheston L; Beattie M; ; ; Neuhausen SL; ; Szabo CI; ; Simard J; Spurdle AB; Healey S; Chen X; Rebbeck TR; Easton DF; Chenevix-Trench G; Antoniou AC; Couch FJ
    Breast Cancer Res Treat; 2012 Nov; 136(1):295-302. PubMed ID: 23011509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
    Barnes DR; Rookus MA; McGuffog L; Leslie G; Mooij TM; Dennis J; Mavaddat N; Adlard J; Ahmed M; Aittomäki K; Andrieu N; Andrulis IL; Arnold N; Arun BK; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Benitez J; Berthet P; Białkowska K; Blanco AM; Blok MJ; Bonanni B; Boonen SE; Borg Å; Bozsik A; Bradbury AR; Brennan P; Brewer C; Brunet J; Buys SS; Caldés T; Caligo MA; Campbell I; Christensen LL; Chung WK; Claes KBM; Colas C; ; ; Collonge-Rame MA; Cook J; Daly MB; Davidson R; de la Hoya M; de Putter R; Delnatte C; Devilee P; Diez O; Ding YC; Domchek SM; Dorfling CM; Dumont M; Eeles R; Ejlertsen B; Engel C; Evans DG; Faivre L; Foretova L; Fostira F; Friedlander M; Friedman E; Frost D; Ganz PA; Garber J; Gehrig A; Gerdes AM; Gesta P; Giraud S; Glendon G; Godwin AK; Goldgar DE; González-Neira A; Greene MH; Gschwantler-Kaulich D; Hahnen E; Hamann U; Hanson H; Hentschel J; Hogervorst FBL; Hooning MJ; Horvath J; Hu C; Hulick PJ; Imyanitov EN; ; ; ; Isaacs C; Izatt L; Izquierdo A; Jakubowska A; James PA; Janavicius R; John EM; Joseph V; Karlan BY; Kast K; Koudijs M; Kruse TA; Kwong A; Laitman Y; Lasset C; Lazaro C; Lester J; Lesueur F; Liljegren A; Loud JT; Lubiński J; Mai PL; Manoukian S; Mari V; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Mensenkamp AR; Miller A; Montagna M; Mouret-Fourme E; Mukherjee S; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Niederacher D; Nielsen FC; Nikitina-Zake L; Noguès C; Olah E; Olopade OI; Ong KR; O'Shaughnessy-Kirwan A; Osorio A; Ott CE; Papi L; Park SK; Parsons MT; Pedersen IS; Peissel B; Peixoto A; Peterlongo P; Pfeiler G; Phillips KA; Prajzendanc K; Pujana MA; Radice P; Ramser J; Ramus SJ; Rantala J; Rennert G; Risch HA; Robson M; Rønlund K; Salani R; Schuster H; Senter L; Shah PD; Sharma P; Side LE; Singer CF; Slavin TP; Soucy P; Southey MC; Spurdle AB; Steinemann D; Steinsnyder Z; Stoppa-Lyonnet D; Sutter C; Tan YY; Teixeira MR; Teo SH; Thull DL; Tischkowitz M; Tognazzo S; Toland AE; Trainer AH; Tung N; van Engelen K; van Rensburg EJ; Vega A; Vierstraete J; Wagner G; Walker L; Wang-Gohrke S; Wappenschmidt B; Weitzel JN; Yadav S; Yang X; Yannoukakos D; Zimbalatti D; Offit K; Thomassen M; Couch FJ; Schmutzler RK; Simard J; Easton DF; Chenevix-Trench G; Antoniou AC;
    Genet Med; 2020 Oct; 22(10):1653-1666. PubMed ID: 32665703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
    Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; ; Thomassen M; Gerdes AM; Sunde L; Cruger D; Birk Jensen U; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; ; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; van der Luijt RB; van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; ; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; ; Godwin AK; Stoppa-Lyonnet D; de Pauw A; Mazoyer S; Bonadona V; Lasset C; Dreyfus H; Leroux D; Hardouin A; Berthet P; Faivre L; ; Loustalot C; Noguchi T; Sobol H; Rouleau E; Nogues C; Frénay M; Vénat-Bouvet L; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Dressler AC; Gschwantler-Kaulich D; Pfeiler G; Hansen TV; Jønson L; Agnarsson BA; Kirchhoff T; Offit K; Devlin V; Dutra-Clarke A; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov E; Tihomirova L; Blanco I; Lazaro C; Ramus SJ; Sucheston L; Karlan BY; Gross J; Schmutzler R; Wappenschmidt B; Engel C; Meindl A; Lochmann M; Arnold N; Heidemann S; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Kast K; Schönbuchner I; Caldes T; de la Hoya M; Aittomäki K; Nevanlinna H; Simard J; Spurdle AB; Holland H; Chen X; ; Platte R; Chenevix-Trench G; Easton DF;
    Cancer Res; 2010 Dec; 70(23):9742-54. PubMed ID: 21118973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
    Osorio A; Milne RL; Kuchenbaecker K; Vaclová T; Pita G; Alonso R; Peterlongo P; Blanco I; de la Hoya M; Duran M; Díez O; Ramón Y Cajal T; Konstantopoulou I; Martínez-Bouzas C; Andrés Conejero R; Soucy P; McGuffog L; Barrowdale D; Lee A; ; Arver B; Rantala J; Loman N; Ehrencrona H; Olopade OI; Beattie MS; Domchek SM; Nathanson K; Rebbeck TR; Arun BK; Karlan BY; Walsh C; Lester J; John EM; Whittemore AS; Daly MB; Southey M; Hopper J; Terry MB; Buys SS; Janavicius R; Dorfling CM; van Rensburg EJ; Steele L; Neuhausen SL; Ding YC; Hansen TV; Jønson L; Ejlertsen B; Gerdes AM; Infante M; Herráez B; Moreno LT; Weitzel JN; Herzog J; Weeman K; Manoukian S; Peissel B; Zaffaroni D; Scuvera G; Bonanni B; Mariette F; Volorio S; Viel A; Varesco L; Papi L; Ottini L; Tibiletti MG; Radice P; Yannoukakos D; Garber J; Ellis S; Frost D; Platte R; Fineberg E; Evans G; Lalloo F; Izatt L; Eeles R; Adlard J; Davidson R; Cole T; Eccles D; Cook J; Hodgson S; Brewer C; Tischkowitz M; Douglas F; Porteous M; Side L; Walker L; Morrison P; Donaldson A; Kennedy J; Foo C; Godwin AK; Schmutzler RK; Wappenschmidt B; Rhiem K; Engel C; Meindl A; Ditsch N; Arnold N; Plendl HJ; Niederacher D; Sutter C; Wang-Gohrke S; Steinemann D; Preisler-Adams S; Kast K; Varon-Mateeva R; Gehrig A; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S; Damiola F; Poppe B; Claes K; Piedmonte M; Tucker K; Backes F; Rodríguez G; Brewster W; Wakeley K; Rutherford T; Caldés T; Nevanlinna H; Aittomäki K; Rookus MA; van Os TA; van der Kolk L; de Lange JL; Meijers-Heijboer HE; van der Hout AH; van Asperen CJ; Gómez Garcia EB; Hoogerbrugge N; Collée JM; van Deurzen CH; van der Luijt RB; Devilee P; ; Olah E; Lázaro C; Teulé A; Menéndez M; Jakubowska A; Cybulski C; Gronwald J; Lubinski J; Durda K; Jaworska-Bieniek K; Johannsson OT; Maugard C; Montagna M; Tognazzo S; Teixeira MR; Healey S; ; Olswold C; Guidugli L; Lindor N; Slager S; Szabo CI; Vijai J; Robson M; Kauff N; Zhang L; Rau-Murthy R; Fink-Retter A; Singer CF; Rappaport C; Geschwantler Kaulich D; Pfeiler G; Tea MK; Berger A; Phelan CM; Greene MH; Mai PL; Lejbkowicz F; Andrulis I; Mulligan AM; Glendon G; Toland AE; Bojesen A; Pedersen IS; Sunde L; Thomassen M; Kruse TA; Jensen UB; Friedman E; Laitman Y; Shimon SP; Simard J; Easton DF; Offit K; Couch FJ; Chenevix-Trench G; Antoniou AC; Benitez J
    PLoS Genet; 2014 Apr; 10(4):e1004256. PubMed ID: 24698998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers.
    Park JS; Lee ST; Han JW; Kim TI; Nam EJ; Park HS
    Clin Breast Cancer; 2018 Oct; 18(5):362-373.e1. PubMed ID: 29673794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Schrijver LH; Antoniou AC; Olsson H; Mooij TM; Roos-Blom MJ; Azarang L; Adlard J; Ahmed M; Barrowdale D; Davidson R; Donaldson A; Eeles R; Evans DG; Frost D; Henderson A; Izatt L; Ong KR; Bonadona V; Coupier I; Faivre L; Fricker JP; Gesta P; van Engelen K; Jager A; Menko FH; Mourits MJE; Singer CF; Tan YY; Foretova L; Navratilova M; Schmutzler RK; Ellberg C; Gerdes AM; Caldes T; Simard J; Olah E; Jakubowska A; Rantala J; Osorio A; Hopper JL; Phillips KA; Milne RL; Beth Terry M; Noguès C; Engel C; Kast K; Goldgar DE; van Leeuwen FE; Easton DF; Andrieu N; Rookus MA;
    Am J Obstet Gynecol; 2021 Jul; 225(1):51.e1-51.e17. PubMed ID: 33493488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?
    Teixeira N; van der Hout A; Oosterwijk JC; Vos JR; ; Devilee P; van Engelen K; Meijers-Heijboer H; van der Luijt RB; Kriege M; Mensenkamp AR; Rookus MA; van Roozendaal KE; Mourits MJE; de Bock GH
    Eur J Hum Genet; 2018 Jun; 26(6):848-857. PubMed ID: 29483665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.
    Jakubowska A; Rozkrut D; Antoniou A; Hamann U; Lubinski J
    Breast Cancer Res Treat; 2010 Jun; 121(3):639-49. PubMed ID: 19876733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.